|
US7147851B1
(en)
*
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
|
US7122636B1
(en)
|
1997-02-21 |
2006-10-17 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and uses of same
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
AU2011226857B2
(en)
*
|
1998-05-13 |
2013-09-19 |
Genentech, Inc. |
Diagnosis and treatment of hepatic disorders
|
|
US7090845B2
(en)
*
|
1998-05-13 |
2006-08-15 |
Genentech, Inc. |
Diagnosis and treatment of hepatic disorders
|
|
WO2000030681A1
(en)
*
|
1998-11-25 |
2000-06-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
|
|
PT1173201E
(pt)
*
|
1999-04-22 |
2005-08-31 |
Biogen Idec Inc |
Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
|
|
AU2006220426B2
(en)
*
|
2000-04-14 |
2008-10-30 |
Genentech Inc. |
Method of administering an antibody
|
|
US20010046496A1
(en)
*
|
2000-04-14 |
2001-11-29 |
Brettman Lee R. |
Method of administering an antibody
|
|
US7658924B2
(en)
*
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
US7521053B2
(en)
*
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
|
CA2470643C
(en)
*
|
2001-12-17 |
2011-10-18 |
Bryan Paul Morgan |
Cleavable reagents for specific delivery to disease sites
|
|
ATE417858T1
(de)
|
2002-02-05 |
2009-01-15 |
Genentech Inc |
Proteinaufreinigung
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2003265235A1
(en)
|
2002-04-26 |
2003-12-19 |
Genetech, Inc. |
Non-affinity purification of proteins
|
|
DK1507556T3
(en)
*
|
2002-05-02 |
2016-09-12 |
Wyeth Holdings Llc |
Calicheamicin derivative-carrier conjugates
|
|
GB0210121D0
(en)
*
|
2002-05-02 |
2002-06-12 |
Celltech R&D Ltd |
Biological products
|
|
EP2368578A1
(en)
*
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
|
NZ567324A
(en)
*
|
2003-02-01 |
2009-08-28 |
Wyeth Corp |
Active immunization to generate antibodies to soluble A-beta
|
|
PT3095793T
(pt)
|
2003-07-28 |
2020-05-04 |
Genentech Inc |
Redução da lixiviação de proteína a durante a cromatografia por afinidade com proteína a
|
|
EP1660094A4
(en)
|
2003-08-26 |
2009-09-16 |
Univ Colorado |
INHIBITORS OF SERINE PROTEASE ACTIVITY AND USES THEREOF IN METHODS AND PREPARATIONS FOR TREATING BACTERIAL INFECTIONS
|
|
EP2135619A1
(en)
|
2003-12-10 |
2009-12-23 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
|
SI2177537T1
(sl)
|
2004-01-09 |
2012-01-31 |
Pfizer |
Protitielesa proti MAdCAM
|
|
US7662926B2
(en)
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
|
US7655229B2
(en)
|
2004-09-02 |
2010-02-02 |
Chan Andrew C |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
|
HUE058817T2
(hu)
*
|
2004-09-03 |
2022-09-28 |
Genentech Inc |
Humanizált anti-béta7 antagonisták és alkalmazásaik
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
JP2008523815A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのヒト化アミロイドβ抗体
|
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
|
WO2007007151A2
(en)
*
|
2005-07-11 |
2007-01-18 |
Pfizer Limited |
Use of anti-mad-cam antibody for the treatment of emphysema
|
|
WO2007007160A2
(en)
*
|
2005-07-11 |
2007-01-18 |
Pfizer Limited |
Anti-madcam antibodies to treat fever
|
|
AU2006316629A1
(en)
*
|
2005-11-17 |
2007-05-31 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
MX2009007632A
(es)
|
2007-01-22 |
2009-07-24 |
Genentech Inc |
Precipitacion de polielectrolito y purificacion de proteinas.
|
|
WO2008108986A2
(en)
*
|
2007-03-02 |
2008-09-12 |
Amgen Inc. |
Methods and compositions for treating tumor diseases
|
|
JP2010521966A
(ja)
*
|
2007-03-20 |
2010-07-01 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
α４β７インテグリンに結合するヒト化免疫グロブリンをコードする核酸
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
DK2158315T3
(en)
|
2007-06-25 |
2016-06-06 |
Esbatech Alcon Biomed Res Unit |
Methods of modifying antibodies and modified antibodies with improved functional properties
|
|
MX354993B
(es)
|
2007-07-09 |
2018-03-28 |
Genentech Inc |
Prevención de reducción de enlaces de disulfuro durante la producción recombinante de polipéptidos.
|
|
ES2498040T3
(es)
*
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
BRPI0817182A2
(pt)
|
2007-10-30 |
2015-03-17 |
Genentech Inc |
Método para purificar um anticorpo e composições
|
|
JP5440179B2
(ja)
*
|
2008-01-11 |
2014-03-12 |
アステラス製薬株式会社 |
改良型ヒト化抗ヒトα９インテグリン抗体
|
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
|
WO2009151514A1
(en)
|
2008-06-11 |
2009-12-17 |
Millipore Corporation |
Stirred tank bioreactor
|
|
CN102149724B
(zh)
|
2008-08-14 |
2014-04-09 |
健泰科生物技术公司 |
使用原地蛋白质置换离子交换膜层析清除污染物的方法
|
|
CA2734275A1
(en)
|
2008-09-10 |
2010-03-18 |
Genentech, Inc. |
Compositions and methods for the prevention of oxidative degradation of proteins
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
US20110020327A1
(en)
|
2008-12-16 |
2011-01-27 |
Millipore Corporation |
Purification of proteins
|
|
CN102257122B
(zh)
|
2008-12-16 |
2015-07-29 |
Emd密理博公司 |
搅拌槽反应器及方法
|
|
CN102333548B
(zh)
|
2009-02-27 |
2013-01-30 |
健泰科生物技术公司 |
用于蛋白质标记的方法和组合物
|
|
AU2016208453B2
(en)
*
|
2009-03-20 |
2018-02-22 |
Amgen Inc. |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
|
AU2013205341B2
(en)
*
|
2009-03-20 |
2016-05-05 |
Amgen Inc. |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
|
EP2408816B1
(en)
*
|
2009-03-20 |
2019-09-04 |
Amgen Inc. |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
|
MY160126A
(en)
|
2009-05-13 |
2017-02-28 |
Genzyme Corp |
Anti-human cd52 immunoglobulins
|
|
BR112012002974B1
(pt)
|
2009-08-11 |
2022-06-07 |
Genentech, Inc |
Processo para produzir um anticorpo em uma célula hospedeira de célula ovário de hamster chinês (cho) expressando o referido polipeptídeo
|
|
KR101764449B1
(ko)
|
2009-09-01 |
2017-08-02 |
제넨테크, 인크. |
변형된 단백질 ａ 용리를 통한 증진된 단백질 정제
|
|
EP4406615A3
(en)
|
2009-10-26 |
2024-12-11 |
F. Hoffmann-La Roche AG |
Method for the production of a glycosylated immunoglobulin
|
|
CN106983862A
(zh)
|
2010-03-22 |
2017-07-28 |
弗·哈夫曼-拉罗切有限公司 |
对于稳定含有蛋白质的制剂有用的组合物和方法
|
|
RU2012151500A
(ru)
|
2010-05-03 |
2014-06-10 |
Дженентек, Инк. |
Композиции и способы, пригодные для снижения вязкости белковосодержащих составов
|
|
DK2571903T3
(da)
|
2010-05-17 |
2019-11-04 |
Emd Millipore Corp |
Polymerer, der reagerer på stimuli, til oprensning af biomolekyler
|
|
PL2576580T3
(pl)
|
2010-05-28 |
2017-03-31 |
F.Hoffmann-La Roche Ag |
Zmniejszenie poziomu mleczanu i zwiększenie wytwarzania polipeptydu przez obniżenie poziomu ekspresji dehydrogenazy mleczanowej i kinazy dehydrogenazy pirogronianowej
|
|
MY184736A
(en)
|
2010-06-24 |
2021-04-20 |
Genentech Inc |
Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
|
|
CN104474546A
(zh)
|
2010-08-13 |
2015-04-01 |
弗·哈夫曼-拉罗切有限公司 |
用于疾病治疗的针对IL-1β和IL-18的抗体
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
US10040855B2
(en)
|
2011-05-02 |
2018-08-07 |
Millennium Pharmaceuticals, Inc. |
Formulation for anti-α4β7 antibody
|
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
|
CA2839917A1
(en)
|
2011-06-24 |
2012-12-27 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
HRP20181846T1
(hr)
|
2011-12-22 |
2018-12-28 |
Genentech, Inc. |
Kromatografija membranom za ionsku izmjenu
|
|
US10745468B2
(en)
|
2011-12-22 |
2020-08-18 |
Kota Biotherapeutics, Llc |
Compositions and methods for modified B cells expressing reassigned biological agents
|
|
AU2013202648B2
(en)
*
|
2012-01-10 |
2016-05-19 |
Konkuk University |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
EA034583B1
(ru)
*
|
2012-01-12 |
2020-02-21 |
Милленниум Фармасьютикалз, Инк. |
ПРИМЕНЕНИЯ АНТИ-α4β7 АНТИТЕЛА
|
|
SG10202007206WA
(en)
|
2012-03-27 |
2020-08-28 |
Genentech Inc |
Improved harvest operations for recombinant proteins
|
|
CN103374073A
(zh)
*
|
2012-04-26 |
2013-10-30 |
中国科学院上海生命科学研究院 |
识别活化形式整合素α4β7的人源化单克隆抗体
|
|
AU2013262611B2
(en)
|
2012-05-18 |
2018-03-01 |
Genentech, Inc. |
High-concentration monoclonal antibody formulations
|
|
CN104994885B
(zh)
|
2012-12-19 |
2017-09-29 |
基因泰克公司 |
用于放射性卤素蛋白质标记的方法和组合物
|
|
AR095199A1
(es)
|
2013-03-15 |
2015-09-30 |
Genzyme Corp |
Anticuerpos anti-cd52
|
|
EP3166401B1
(en)
|
2014-07-09 |
2020-08-19 |
F. Hoffmann-La Roche AG |
Ph adjustment to improve thaw recovery of cell banks
|
|
MA40592A
(fr)
|
2014-10-06 |
2016-04-14 |
Chemocentryx Inc |
Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7
|
|
WO2016086147A1
(en)
|
2014-11-26 |
2016-06-02 |
Millennium Pharmaceuticals, Inc. |
Vedolizumab for the treatment of fistulizing crohn's disease
|
|
US20170360926A1
(en)
|
2014-12-24 |
2017-12-21 |
Millennium Pharmaceuticals, Inc. |
PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY
|
|
MA41636A
(fr)
|
2015-03-06 |
2018-01-09 |
Millennium Pharm Inc |
Méthode de traitement de la cholangite sclérosante primitive
|
|
JP6548052B2
(ja)
|
2015-08-11 |
2019-07-24 |
国立大学法人大阪大学 |
抗体
|
|
JP6951825B2
(ja)
|
2015-09-04 |
2021-10-20 |
ザ スクリプス リサーチ インスティテュート |
インスリン免疫グロブリン融合タンパク質
|
|
CA3048613A1
(en)
|
2015-12-31 |
2017-07-06 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods and uses for alpha-1 antitrypsin or recombinant forms thereof, on steroid-refractory graft versus host disease involving gastrointestinal complications
|
|
CA3017743A1
(en)
*
|
2016-03-14 |
2017-09-21 |
Millennium Pharmaceuticals, Inc. |
Method of preventing graft versus host disease
|
|
WO2017160700A1
(en)
*
|
2016-03-14 |
2017-09-21 |
Millennium Pharmaceuticals, Inc. |
Methods of treating or preventing graft versus host disease
|
|
US11760803B2
(en)
|
2016-03-24 |
2023-09-19 |
Takeda Pharmaceutical Company Limited |
Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
|
|
WO2017165742A1
(en)
|
2016-03-24 |
2017-09-28 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
|
|
KR20190012145A
(ko)
|
2016-03-29 |
2019-02-08 |
젤터, 인코포레이티드 |
주변세포질 부피 대 세포질 부피의 비가 0.5:1 내지 10:1인 그람-음성 박테리아에서의 단백질의 발현
|
|
MA44864A
(fr)
|
2016-05-04 |
2019-03-13 |
Icahn School Med Mount Sinai |
Trithérapie pour le traitement d'une maladie intestinale inflammatoire
|
|
CN109563482A
(zh)
*
|
2016-06-10 |
2019-04-02 |
埃尔瓦有限公司 |
含表达异于分泌免疫球蛋白和细胞溶解功能的膜免疫球蛋白的b淋巴细胞系的组合物和方法
|
|
US11389533B2
(en)
|
2016-06-12 |
2022-07-19 |
Takeda Pharmaceutical Company Limited |
Method of treating inflammatory bowel disease
|
|
WO2018104893A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
|
|
AU2017382281B2
(en)
|
2016-12-22 |
2024-07-11 |
Genentech, Inc. |
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
|
|
BR112019022268A2
(pt)
|
2017-04-28 |
2020-05-19 |
Millennium Pharmaceuticals, Inc. |
método para o tratamento de distúrbios pediátricos
|
|
CR20200076A
(es)
|
2017-07-14 |
2020-06-10 |
Pfizer |
ANTICUERPOS CONTRA MAdCAM
|
|
US11180541B2
(en)
|
2017-09-28 |
2021-11-23 |
Geltor, Inc. |
Recombinant collagen and elastin molecules and uses thereof
|
|
EP4368699A3
(en)
|
2018-07-03 |
2024-09-11 |
Bristol-Myers Squibb Company |
Methods of producing recombinant proteins
|
|
WO2020076776A1
(en)
|
2018-10-10 |
2020-04-16 |
Boehringer Ingelheim International Gmbh |
Method for membrane gas transfer in high density bioreactor culture
|
|
CA3121168A1
(en)
*
|
2018-11-30 |
2020-06-04 |
Memorial Sloan Kettering Cancer Center |
Heterodimeric tetravalency and specificity antibody compositions and uses thereof
|
|
AR118536A1
(es)
|
2019-04-01 |
2021-10-20 |
Genentech Inc |
Composiciones y métodos para estabilizar formulaciones que contienen proteína
|
|
GB2597416A
(en)
|
2019-04-12 |
2022-01-26 |
Geltor Inc |
Recombinant elastin and production thereof
|
|
MA55735A
(fr)
*
|
2019-04-17 |
2022-02-23 |
Millennium Pharm Inc |
Polythérapie à base d'inhibiteur d'alpha4bêta7 et d'inhibiteur d'il-23
|
|
CN117925710A
(zh)
*
|
2019-06-10 |
2024-04-26 |
武田药品工业株式会社 |
用于抗体生产的细胞培养方法和组合物
|
|
JP7753105B2
(ja)
*
|
2019-06-10 |
2025-10-14 |
武田薬品工業株式会社 |
抗体の精製方法及びその組成物
|
|
US20220315887A1
(en)
|
2019-08-01 |
2022-10-06 |
Bristol-Myers Squibb Company |
Methods of improving protein productivity in fed-batch cell cultures
|
|
JP7808097B2
(ja)
|
2020-09-22 |
2026-01-28 |
ブリストル－マイヤーズ スクイブ カンパニー |
治療タンパク質を生産するための方法
|
|
WO2023015234A1
(en)
|
2021-08-05 |
2023-02-09 |
Bristol-Myers Squibb Company |
Cell culture methods for producing therapeutic proteins
|
|
US20240390869A1
(en)
|
2021-09-21 |
2024-11-28 |
Bristol-Myers Squibb Company |
Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container
|
|
IL317511A
(en)
|
2022-06-16 |
2025-02-01 |
Cephalon Llc |
IL-2 immunoconjugates attenuated by anti-PD-1 antibody and their uses
|
|
TW202504919A
(zh)
|
2023-05-30 |
2025-02-01 |
美商派拉岡醫療公司 |
α4β7整合素抗體組合物及使用方法
|
|
WO2024252368A2
(en)
|
2023-06-09 |
2024-12-12 |
Takeda Pharmaceutical Company Limited |
Methods and compositions for treating ulcerative colitis
|
|
WO2025137093A1
(en)
|
2023-12-19 |
2025-06-26 |
Cephalon Llc |
Uses for attenuated il-2 immunoconjugates
|
|
CN117777292B
(zh)
*
|
2023-12-28 |
2024-10-18 |
天津大学 |
抗整合素α4β7纳米抗体及其用途
|
|
WO2025149974A1
(en)
|
2024-01-11 |
2025-07-17 |
Takeda Pharmaceutical Company Limited |
Combination therapy with an anti-alpha4beta7 antibody
|
|
WO2025177214A1
(en)
|
2024-02-20 |
2025-08-28 |
Takeda Pharmaceutical Company Limited |
Therapeutic methods
|